Daniel J. Lippis
Known title: CVP, TAVRCIK: 0002004380
Associated companies
Transaction History
| EW | ▲ Buy | Option Exercise | 619 | $45K | 10/8/2026 | View on chart |
| EW | ▼ Sell | Open Market | 619 | $53K | 10/8/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 619 | $45K | 9/11/2026 | View on chart |
| EW | ▼ Sell | Open Market | 619 | $54K | 9/11/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 619 | $45K | 8/11/2026 | View on chart |
| EW | ▼ Sell | Open Market | 619 | $57K | 8/11/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 619 | $45K | 7/10/2026 | View on chart |
| EW | ▼ Sell | Open Market | 619 | $57K | 7/10/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 377 | $36K | 7/7/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 619 | $45K | 6/30/2026 | View on chart |
| EW | ▼ Sell | Open Market | 619 | $57K | 6/30/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 620 | $45K | 5/18/2026 | View on chart |
| EW | ▼ Sell | Open Market | 620 | $50K | 5/18/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 362 | $29K | 5/11/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 450 | $37K | 5/8/2026 | View on chart |
| EW | ▲ Buy | Grant | 7,850 | $0 | 5/7/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 309 | $26K | 5/7/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,019 | $60K | 5/4/2026 | View on chart |
| EW | ▼ Sell | Open Market | 1,019 | $86K | 5/4/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 252 | $21K | 5/3/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,019 | $60K | 5/1/2026 | View on chart |
| EW | ▼ Sell | Open Market | 19 | $2K | 5/1/2026 | View on chart |
| EW | ▼ Sell | Open Market | 1,000 | $83K | 5/1/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,019 | $60K | 4/6/2026 | View on chart |
| EW | ▼ Sell | Open Market | 1,019 | $83K | 4/6/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,019 | $60K | 3/11/2026 | View on chart |
| EW | ▼ Sell | Open Market | 1,019 | $87K | 3/11/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 432 | $34K | 2/22/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 198 | $15K | 2/17/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 258 | $20K | 2/16/2026 | View on chart |
| EW | ▲ Buy | Grant | 12,820 | $0 | 2/12/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,019 | $60K | 1/9/2026 | View on chart |
| EW | ▼ Sell | Open Market | 1,019 | $87K | 1/9/2026 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,019 | $60K | 12/12/2025 | View on chart |
| EW | ▼ Sell | Open Market | 1,019 | $86K | 12/12/2025 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,020 | $60K | 11/10/2025 | View on chart |
| EW | ▼ Sell | Open Market | 1,020 | $84K | 11/10/2025 | View on chart |
| EW | ▼ Sell | Open Market | 4,114 | $327K | 7/28/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 333 | $26K | 7/7/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 271 | $20K | 5/11/2025 | View on chart |
| EW | ▲ Buy | Option Exercise | 330 | $15K | 5/9/2025 | View on chart |
| EW | ▼ Sell | Open Market | 330 | $25K | 5/9/2025 | View on chart |
| EW | ▲ Buy | Grant | 4,225 | $0 | 5/8/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 247 | $19K | 5/4/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 225 | $17K | 5/3/2025 | View on chart |
| EW | ▲ Buy | Option Exercise | 300 | $14K | 4/8/2025 | View on chart |
| EW | ▼ Sell | Open Market | 300 | $21K | 4/8/2025 | View on chart |
| EW | ▲ Buy | Option Exercise | 400 | $18K | 3/10/2025 | View on chart |
| EW | ▼ Sell | Open Market | 400 | $28K | 3/10/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 222 | $17K | 2/18/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 165 | $13K | 2/17/2025 | View on chart |
| EW | ▼ Sell | Tax Withholding | 214 | $16K | 2/16/2025 | View on chart |
| EW | ▲ Buy | Option Exercise | 500 | $23K | 2/13/2025 | View on chart |
| EW | ▼ Sell | Open Market | 500 | $38K | 2/13/2025 | View on chart |
| EW | ▲ Buy | Option Exercise | 500 | $23K | 1/16/2025 | View on chart |
| EW | ▼ Sell | Open Market | 500 | $34K | 1/16/2025 | View on chart |
| EW | ▲ Buy | Option Exercise | 2,500 | $113K | 12/16/2024 | View on chart |
| EW | ▼ Sell | Open Market | 2,500 | $185K | 12/16/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 500 | $23K | 7/11/2024 | View on chart |
| EW | ▼ Sell | Open Market | 500 | $47K | 7/11/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 410 | $38K | 7/7/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 535 | $24K | 6/20/2024 | View on chart |
| EW | ▼ Sell | Open Market | 535 | $48K | 6/20/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 377 | $33K | 5/11/2024 | View on chart |
| EW | ▲ Buy | Grant | 2,900 | $0 | 5/7/2024 | View on chart |
| EW | ▲ Buy | Grant | 4,660 | $0 | 5/7/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 857 | $31K | 5/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 586 | $50K | 5/7/2024 | View on chart |
| EW | ▼ Sell | Open Market | 857 | $73K | 5/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 291 | $25K | 5/4/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 281 | $24K | 5/3/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 857 | $31K | 4/9/2024 | View on chart |
| EW | ▼ Sell | Open Market | 857 | $79K | 4/9/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 1,715 | $63K | 3/7/2024 | View on chart |
| EW | ▼ Sell | Open Market | 1,715 | $156K | 3/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 188 | $16K | 2/18/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 150 | $13K | 2/17/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 207 | $18K | 2/16/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
EW: FDA Flags High-Risk Device Recall After Patient Death
The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.
EW: FDA Flags High-Risk Device Recall After Patient Death. The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.